Delivery Order SPE2DB20D2104-SPE2DB25FMHKM

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Delivery Order valued at $6,571.65 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a prescription cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,187.57, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 6, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,037.22 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4566964604 BRILINTA 60 MG TABLET 60S, a cardiovascular medication, with a period of performance through January 17, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,371.23, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has a ceiling value of $3,519.14 and runs through September 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of medical commodities...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of BRILINTA 90 MG TABLET 60S, a medication used to treat cardiovascular conditions. The contract has a ceiling value of $1,025.01 and a period of performance running through February 11, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,364.57, is a delivery order for the medication BRILINTA 90 MG TABLET 60S. It has an ultimate completion date of December 22, 2023. The contract is not designated as a set-aside and was awarded as part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and the...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHKB, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, with a firm fixed price ceiling value of $4,494.18 and a period of performance ending on February 5, 2025. The contract is not designated as a set-aside and was awarded...
This federal contract award, valued at $1,079.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRILINTA 60 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $1,263.21 and runs through September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMHKM
    Delivery Order

This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHKM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, with a ceiling value of $3,090.63.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/6/25, 10:51 AM